“

We are providing a tentative schedule for discussion of these submissions, as these meetings will cover a number of topics that are of great interest to the general public, the agency is committed to a thorough and transparent process that considers the input of our independent advisors and provides insight into our review of the COVID-19 vaccines. We intend to move quickly with any authorizations that are appropriate once our work is completed.